Net Loss Per Share - Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities	50,329,713	10,623,937
Series A Preferred Stock [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities	21,818,962
Stock options [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities	7,353,451	8,538,342
Common stock warrants [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities		23,607
2019 LSA Warrants [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities		449,489
2021 LSA Warrants [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities		251,805
2024 LSA Warrants [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities		696,940
2024 LSA Conversion Feature [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities		663,754
PIPE Warrants [Member]
Schedule of Dilutive Common Stock Equivalents Excluded from Computation of Diluted Net Loss Per Share [Line Items]
Antidilutive Securities	21,157,300